当前位置: X-MOL 学术bioRxiv. Cancer Biol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Novel mechanistic targets of Forkhead box Q1 transcription factor in human breast cancer cells
bioRxiv - Cancer Biology Pub Date : 2020-05-29 , DOI: 10.1101/2020.05.26.117176
Su-Hyeong Kim , Eun-Ryeong Hahm , Krishna B. Singh , Shivendra V. Singh

The transcription factor forkhead box Q1 (FoxQ1), which is overexpressed in different solid tumors, has emerged as a key player in the pathogenesis of breast cancer by regulating epithelial-mesenchymal transition, maintenance of cancer-stem like cells, and metastasis. However, the mechanism underlying oncogenic function of FoxQ1 is still not fully understood. In this study, we compared the RNA-seq data from FoxQ1 overexpressing SUM159 cells with that of empty vector-transfected control (EV) cells to identify novel mechanistic targets of this transcription factor. Consistent with published results in basal-like subtype, immunohistochemistry revealed upregulation of FoxQ1 protein in luminal-type human breast cancer tissue microarrays when compared to normal mammary tissues. Many previously reported transcriptional targets of FoxQ1 (e.g., E-cadherin, N-cadherin, fibronectin 1, etc.) were verified from the RNA-Seq analysis. FoxQ1 overexpression resulted in downregulation of genes associated with cell cycle checkpoints, M phase, and cellular response to stress/external stimuli as evidenced from the Reactome pathway analysis. Consequently, FoxQ1 overexpression resulted in S, G2M and mitotic arrest in basal-like SUM159 and HMLE cells, but not in luminal-type MCF-7 cells. There were differences in expression of cell cycle-associated proteins between FoxQ1 overexpressing SUM159 and MCF-7 cells. Finally, we show for the first time that FoxQ1 is a direct transcriptional regulator of interleukin (IL)-1, IL-8, and vascular endothelial growth factor in breast cancer cells. Chromatin immunoprecipitation revealed FoxQ1 occupancy at the promoters of IL-1, IL-8, and VEGF. In conclusion, the present study reports novel mechanistic targets of FoxQ1 in human breast cancer cells.

中文翻译:

人类乳腺癌细胞中叉头盒Q1转录因子的新型机制目标。

在不同的实体瘤中过表达的转录因子叉头盒Q1(FoxQ1)已通过调节上皮-间质转化,癌干样细胞的维持和转移,成为乳腺癌发病机制中的关键角色。但是,FoxQ1致癌功能的潜在机制仍不完全清楚。在这项研究中,我们比较了过表达FoxQ1的SUM159细胞与空载体转染的对照(EV)细胞的RNA-seq数据,以确定该转录因子的新机制靶标。与已发表的基底样亚型的结果一致,免疫组织化学显示与正常乳腺组织相比,管腔型人乳腺癌组织微阵列中的FoxQ1蛋白上调。许多先前报道的FoxQ1转录靶标(例如E-cadherin,从RNA-Seq分析中验证了N-钙粘蛋白,纤连蛋白1等。从Reactome途径分析可以看出,FoxQ1的过表达导致与细胞周期检查点,M期相关的基因下调,以及细胞对应激/外部刺激的反应。因此,FoxQ1过表达导致基底样SUM159和HMLE细胞中的S,G2M和有丝分裂停滞,而在腔型MCF-7细胞中则没有。FoxQ1过表达的SUM159和MCF-7细胞之间的细胞周期相关蛋白表达存在差异。最后,我们首次证明FoxQ1是乳腺癌细胞中白介素(IL)-1,IL-8和血管内皮生长因子的直接转录调节因子。染色质的免疫沉淀显示FoxQ1在IL-1,IL-8和VEGF的启动子上占有。结论,
更新日期:2020-05-29
down
wechat
bug